Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Joel C Marrs

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOP-Administration
Phone303/724-5780

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Anderson SL, Kattappuram RS, Marrs JC, Joseph NM. Intentional Brodifacoum Ingestion. Am J Med. 2017 Jan; 130(1):e27-e28. PMID: 27591180.
      View in: PubMed
    2. Marrs JC, Kostoff MD. Discontinuation of Statins: What Are the Risks? Curr Atheroscler Rep. 2016 Jul; 18(7):41. PMID: 27221503.
      View in: PubMed
    3. Zupec JF, Marrs JC, Saseen JJ. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations. Ann Pharmacother. 2016 Jan; 50(1):17-21. PMID: 26416950.
      View in: PubMed
    4. Amin A, Marrs JC. Direct Oral Anticoagulants for the Management of Thromboembolic Disorders: The Importance of Adherence and Persistence in Achieving Beneficial Outcomes. Clin Appl Thromb Hemost. 2016 Oct; 22(7):605-16. PMID: 26316518.
      View in: PubMed
    5. Marrs JC. Duration of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2015 Apr 02; 372(14):1372. PMID: 25830432.
      View in: PubMed
    6. Wobeter BR, Anderson SL, Marrs JC. Characterization of diastolic dysfunction heart failure following an acute hospitalization for heart failure in an urban, underserved population. Ther Adv Cardiovasc Dis. 2015 Oct; 9(5):267-74. PMID: 25767213.
      View in: PubMed
    7. Fosmire Rundgren EW, Anderson SL, Marrs JC. Response to comment "Evaluation of aspirin use for primary prevention in diabetic patients". Ann Pharmacother. 2015 Feb; 49(2):262-3. PMID: 25583942.
      View in: PubMed
    8. Fosmire Rundgren EW, Anderson SL, Marrs JC. Evaluation of aspirin use in patients with diabetes receiving care in community health. Ann Pharmacother. 2015 Feb; 49(2):170-7. PMID: 25288823.
      View in: PubMed
    9. Anderson SL, Marrs JC, Vande Griend JP, Hanratty R. Implementation of a clinical pharmacy specialist-managed telephonic hospital discharge follow-up program in a patient-centered medical home. Popul Health Manag. 2013 Aug; 16(4):235-41. PMID: 23537153.
      View in: PubMed
    10. Baker WL, Marrs JC, Davis LE, Nutescu EA, Rowe AS, Ryan M, Splinter MY, Vardeny O, Fagan SC. Key articles and guidelines in the primary prevention of ischemic stroke. Pharmacotherapy. 2013 Jun; 33(6):e101-14. PMID: 23401140.
      View in: PubMed
    11. Baker WL, Marrs JC, Davis LE, Nutescu EA, Rowe AS, Ryan M, Splinter MY, Vardeny O, Fagan SC. Key articles and guidelines in the acute management and secondary prevention of ischemic stroke. Pharmacotherapy. 2013 Jun; 33(6):e115-42. PMID: 23401103.
      View in: PubMed
    12. Lowe RN, Marrs JC, Saseen JJ. Patterns of serum laboratory monitoring for safety and efficacy in patients on chronic statin therapy. Ther Adv Drug Saf. 2013 Feb; 4(1):9-17. PMID: 25083247.
      View in: PubMed
    13. Toussaint KA, Watson K, Marrs JC, Sturpe DA, Anderson SL, Haines ST. Prevalence of and factors that influence board certification among pharmacy practice faculty at United States colleges and schools of pharmacy. Pharmacotherapy. 2013 Jan; 33(1):105-11. PMID: 23307551.
      View in: PubMed
    14. Marrs JC. Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl. Drugs Aging. 2012 May 01; 29(5):e1-e12. PMID: 22530704.
      View in: PubMed
    15. Anderson SL, Marrs JC. Dapagliflozin for the treatment of type 2 diabetes. Ann Pharmacother. 2012 Apr; 46(4):590-8. PMID: 22433611.
      View in: PubMed
    16. Marrs JC. Optimizing outcomes in patients with cardiovascular disease and chronic kidney disease. Am J Manag Care. 2011 Dec; 17 Suppl 15:S403-11. PMID: 22214475.
      View in: PubMed
    17. Haines ST, Andrus MR, Badowski M, Bradbury MM, Canales AE, Cavanaugh JM, Koval PG, Lee MW, Marrs JC, Michael Nash J, Ott CA, Robbins Williams A, Wham DL. Board Certification of Pharmacist Specialists. Pharmacotherapy. 2011 Nov; 31(11):1146-9. PMID: 22026401.
      View in: PubMed
    18. Hanselin MR, Saseen JJ, Allen RR, Marrs JC, Nair KV. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension. 2011 Dec; 58(6):1008-13. PMID: 22042809.
      View in: PubMed
    19. Marrs JC. Spironolactone management of resistant hypertension. Ann Pharmacother. 2010 Nov; 44(11):1762-9. PMID: 20978214.
      View in: PubMed
    20. Marrs JC, Saseen JJ. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis. Pharmacotherapy. 2010 Aug; 30(8):823-9. PMID: 20653359.
      View in: PubMed
    21. Williams CD, Marrs JC, Fields SA. Addition of a clinical pharmacist to an inpatient family medicine service. Am J Health Syst Pharm. 2010 Jun 15; 67(12):965-6. PMID: 20516461.
      View in: PubMed
    22. Marrs JC, Rackham DM. Residents' challenging role: Preceptee, preceptor, or both? Am J Health Syst Pharm. 2010 Feb 01; 67(3):239-43. PMID: 20101068.
      View in: PubMed
    23. Proposed revision to the existing specialty and specialist certification framework for pharmacy practitioners. Pharmacotherapy. 2009 Apr; 29(4):3e-13e. PMID: 19323626.
      View in: PubMed
    24. Marrs JC. Colesevelam for the management of type 2 diabetes. Expert Opin Drug Metab Toxicol. 2009 Feb; 5(2):187-94. PMID: 19239397.
      View in: PubMed
    25. Marrs JC. Indiplon: a nonbenzodiazepine sedative-hypnotic for the treatment of insomnia. Ann Pharmacother. 2008 Jul; 42(7):1070-9. PMID: 18594049.
      View in: PubMed
    26. Marrs JC, Saseen JJ. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients. Pharmacotherapy. 2008 May; 28(5):562-9. PMID: 18447654.
      View in: PubMed
    27. Marrs JC, Saseen JJ. Which patients are candidates for dipeptidyl peptidase IV inhibitors? Am J Health Syst Pharm. 2007 Jun; 64(12):1261. PMID: 17563046.
      View in: PubMed
    28. Ito MK, Marrs J, Williams C. Omacor effects on serum lipids and clinical outcome. Am J Cardiol. 2007 Jan 01; 99(1):145. PMID: 17196478.
      View in: PubMed
    29. Marrs JC. Family medicine pharmacy residency programs. Am J Health Syst Pharm. 2006 Oct 01; 63(19):1803-5. PMID: 16990624.
      View in: PubMed
    30. Molitoris BA, Marrs J. The role of cell adhesion molecules in ischemic acute renal failure. Am J Med. 1999 May; 106(5):583-92. PMID: 10335732.
      View in: PubMed
    Marrs's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)